science top stories popular news  

Daily non-political popular news in brief.

Novel test identifies leukemia patients likely to respond to new therapy

02-20-2007 · EurekAlert!

Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.

Read more »

Keywords: novel, test, identifies, leukemia, patients, likely, respond, therapy, identify, patient

« Previous | Next »

Similar news on "Novel test identifies leukemia patients likely to respond to new therapy":

  1. Novel test identifies lymphoma patients likely to respond to new therapy
    02-20-2007 · EurekAlert!
    Researchers at the Albert Einstein College of Medicine of Yeshiva University have discovered a genetic signature identifying cases of lymphoma that are uniquely susceptible to a newly developed molecular targeted therapy. As a result, physicians organizing clinical trials of the new therapy will be able to enroll patients who'll be most likely to benefit from it.
    Similar news · Read more »
  2. Molecules might identify high-risk acute-leukemia patients
    01-15-2008 · EurekAlert!
    New research suggests that certain microRNAs might help doctors identify adult acute-leukemia patients who are likely to respond poorly to therapy. The findings showed that both the leukemia cells and their normal counterparts had similar kinds of microRNA, but that the two groups differed in the levels of miRNAs present. The study should improve the understanding of acute myeloid leukemia and could lead to new therapies for patients with few treatment options.
    Similar news · Read more »
  3. Simple two-in-one test signals high risk after a heart attack
    12-03-2007 · EurekAlert!
    Everyone loves a two-fer, but a two-in-one heart test that has the potential to save lives is the real deal. According to new research, pairing two findings from one simple test makes it significantly more likely that doctors will identify patients who face the greatest risk after a heart attack.
    Similar news · Read more »
  4. UF researchers test stem cell therapy for heart patients
    10-04-2007 · EurekAlert!
    University of Florida doctors treated the first patient in a new study to test whether a person's own stem cells can be used to restore blood flow to the heart by prompting new blood vessels to grow.
    Similar news · Read more »
  5. Study identifies characteristics of clinicians likely to order inappropriate prostate screenings
    07-09-2007 · EurekAlert!
    Prostate-specific antigen tests to screen for prostate cancer are frequently performed among patients for whom the PSA test is not shown to be beneficial, and clinicians with certain characteristics are more likely to order such inappropriate screening tests, according to a report in the July 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
    Similar news · Read more »
  6. Study identifies women with breast cancer most likely to benefit from aromatase inhibitor
    10-23-2006 · EurekAlert!
    While some breast cancer survivors could benefit from adding aromatase inhibitors to the standard five years of tamoxifen, a new study shows the additional therapy should be weighed carefully for each individual. Tthe study's authors say potential improvement in cancer-free survival beyond five years with the added therapy may be less than two percent for most patients.
    Similar news · Read more »
  7. Genetic approach provides new insight into trastuzumab resistance in breast cancer
    10-15-2007 · EurekAlert!
    A new study provides important insight into the mechanisms involved in resistance to treatment of breast cancer patients with trastuzumab (Herceptin). The research, published by Cell Press in the October issue of the journal Cancer Cell, identifies markers that may help to identify patients who are unlikely to respond to trastuzumab treatment and provides a potential strategy for treating these patients.
    Similar news · Read more »
  8. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
    09-06-2007 · EurekAlert!
    A new study has found an unexpected number of viruses and viral subtypes in patients with respiratory tract infections. The technique used in the study may help identify new viruses associated with human diseases. The study is published in the Sept. 15 issue of the Journal of Infectious Diseases, now available online.
    Similar news · Read more »
  9. Researchers identify new therapy for patients with Crohn's disease
    05-01-2007 · EurekAlert!
    A study led by Mayo Clinic found that adalimumab ((HUMIRA) is an effective treatment for adults with Crohn's disease who do not respond to infliximab (REMICADE)) therapy. These findings were published online today by Annals of Internal Medicine.
    Similar news · Read more »
  10. Gene's activity points to more lethal subtype of AML
    07-09-2007 · EurekAlert!
    A new study shows that the activity of a particular gene can identify people who have a more lethal form of acute myeloid leukemia, singling out those patients who should receive more intense therapy. The gene, called ERG (for ETS-related gene), has also been linked to chronic leukemia and to breast and prostate cancer.
    Similar news · Read more »